Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MAXIMO F NOUGUES Insider Profile
4 Followers
MAXIMO F NOUGUES, CFO at Puma Biotechnology, holds 162.52K shares in Puma Biotechnology (Ticker: PBYI).
Profitable Transactions
14 out of 26 Profitable Transactions
Average Return
+17.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of MAXIMO F NOUGUES's holdings
Insider Roles
CFO
Roles that MAXIMO F NOUGUES holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 04, 2021 - Feb 04, 2022
Return:+80.00%
The most profitable trade made by MAXIMO F NOUGUES
MAXIMO F NOUGUES's Trading History
List of latest transactions for each holding click on a transaction to see MAXIMO F NOUGUES's performance on stock
You May Also Like
MAXIMO F NOUGUES insider profile FAQ
What is the percentage of profitable transactions made by MAXIMO F NOUGUES?
The percentage of profitable transactions made by MAXIMO F NOUGUES is 54%.
What is the average return per transaction made by MAXIMO F NOUGUES?
The average return per transaction made by MAXIMO F NOUGUES is 17.60%.
What stocks does MAXIMO F NOUGUES hold?
MAXIMO F NOUGUES holds: PBYI stocks.
What was MAXIMO F NOUGUES’s latest transaction?
MAXIMO F NOUGUES latest transaction was an Uninformative Sell of $15.38K.
What was MAXIMO F NOUGUES's most profitable transaction?
MAXIMO F NOUGUES’s most profitable transaction was an Informative Sell of PBYI stock on February 4, 2021. The return on the trade was 80.00%.
What is MAXIMO F NOUGUES's role in Puma Biotechnology?
MAXIMO F NOUGUES's role in Puma Biotechnology is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.